The clinical and pathologic features of 70 juvenile granulosa cell tumors (JGCTs) of the testis are presented. The patients were from 30 weeks gestational age to 10 years old; 60 of 67 (90%) whose ages are known to us were 6 months old or younger. Sixty-two underwent gonadectomy, 6 wedge excision, and 2 only biopsy. Twenty-six tumors were left sided and 22 right sided. Six occurred in an undescended testis and 2 in dysgenetic gonads. The most common presentation was a testicular mass (65%), followed by an "enlarging testis" (25%).
I n the late 1960s to early 1970s, the late Dr Robert E.
Scully became aware that in the ovary granulosa cell tumors in the young often had different characteristics from those occurring in the more typical older patient and coined the designation "juvenile granulosa cell tumor" (JGCT) for them. He first widely popularized the term in his first fascicle on ovarian tumors, published in 1979. 1 Circa the time of publication of that work, he began to observe a similar profile (more varied follicular architecture and immature nuclei with greater mitotic activity) in testicular granulosa cell tumors in the very young. Logically, he referred to the testicular tumors by the same name. Soon after the first example of JGCT of the testis was reported in the literature, 2 Dr Scully's experience with 14 cases was described 2 years later. 3 Over the years it has become apparent that criteria for the diagnosis of this neoplasm in the testis are not applied uniformly by individual investigators, and the spectrum acceptable for this designation has been debated. To explore this aspect and record our own now significantly expanded experience with JGCTs of the testis, we report our experience to date herein.
MATERIALS AND METHODS
A search of the consultation files at the Massachusetts General Hospital uncovered 51 cases of JGCT of the testis, many from the consultation collection of the late Dr Robert E. Scully; 14 of them were previously reported. 3, 4 A computer-based text search of the surgical pathology files of Indiana University revealed 19 more cases. Clinical data including age, presentation, serum tumor markers, and follow-up information were recorded. The gross features, histologic patterns, cytologic features, presence of intratubular component, mitotic rate, apoptotic activity, lymphovascular invasion, necrosis, and nature of the stroma were assessed. All cases with available material were stained with antibodies directed against inhibin, calretinin, Wilms tumor 1 (WT1), SOX9, FOXL2, and steroidogenic factor-1 (SF-1). In addition, all immunostains previously performed were reviewed and results documented. The study was approved by the Institutional Review Board of Indiana University.
The antibody sources, dilutions, antigen retrieval methods, and incubations are summarized in Table 1 . Immunostaining studies of whole sections of formalinfixed, paraffin-embedded tissue directed against SF-1, inhibin, calretinin, and WT1 were conducted using a polymer-based method (EnVision FLEX or FLEX+; Dako, Carpinteria, CA), with diaminobenzidine as the chromogen and a Dako automated immunostaining instrument. Those directed against SOX9 and FOXL2 were conducted using a different polymer-based method (donkey-anti-goat, Jackson ImmunoResearch Labs and LSAB2-SA; Dako), with diaminobenzidine as the chromogen and a Dako automated immunostaining instrument. Negative and positive controls were performed for each immunohistochemical (IHC) stain. Only nuclear reactivity was considered positive for SOX9, FOXL2, SF-1, and WT1; the presence of cytoplasmic staining without nuclear reactivity was considered negative. Both nuclear and cytoplasmic reactivity was required for calretinin.
RESULTS

Clinical Features
The patients ranged from 30 weeks gestational age to 10 years old; 34 were r1 month, 8 >1 but r2 months, 8 >2 but r3 months, 4 >3 but r4 months, 5 >4 but r5 months, 1 >5 but r6 months, 3 >6 months but r1 year, and 4 >1 year old (14 mo, 21 mo, 6 y, and 10 y). One patient had gynecomastia, and 6 of 14 had an "elevated," likely physiologically, serum a-fetoprotein (AFP) level. Forty-one patients were noted to have a testicular mass and 16 "testicular swelling"; 2 of the latter had torsion. The remaining 6 patients presented with extratesticular "masses," later revealed to be neoplasms in undescended testes. Two tumors were found in dysgenetic gonads (karyotype showed 46XX and 45XO/46XY mosaic) and have been previously reported. 4 The tumor was slightly more commonly located in the left testis (n = 26) than the right (n = 22) in cases in which laterality is known to us.
Pathologic Features
The tumors measured 0.5 to 5 cm (mean, 1.7 cm; median, 1.5 cm) in maximum dimension and were mostly well circumscribed (94%). Of the 41 cases with an available gross description, 26 were cystic (13 multilocular) and 15 solid (Fig. 1 ). The latter component varied from yellow-tan to gray-white; 7 had a cut surface that was sometimes described as mucoid, gelatinous, or glistening ( Fig. 1 ). Microscopic examination showed that all had at least a focal lobular appearance on low power, with the lobules separated by a variably cellular stroma (Figs. 2, 3A). Sixty-seven (96%) were punctuated by variably sized and shaped follicles (Figs. 2, 3B, 4-6) containing basophilic material (21%), eosinophilic material (44%), or both (35%). Mixed follicular and solid patterns occurred in 55 cases (79%), with follicular predominance in 33 (47%) and solid predominance in 22 (32%). The follicles ranged from small and round to large, irregular, and cystically dilated (Figs. 2, 4-6). Purely follicular or purely solid ( Fig. 3A ) appearances were less common, 12 (17%) and 3 (4%), respectively. The follicles were lined by either a single layer or multiple layers of rounded cells (Fig. 5 ).
In nonfollicular areas, the tumor cells typically grew diffusely, but occasionally grew as cords (26%) or had a reticular appearance (29%) (Fig. 7) . The stroma was fibrous or fibromyxoid in an equal number of cases (Figs. 8, 9) and occasionally had hemorrhage associated with hemosiderin-laden macrophages (16%). Occasionally, myxoid stroma merged imperceptibly with similarly staining follicular fluid (Fig. 9B ).
The tumor cells were mostly small to medium sized (91%) with round to oval nuclei (63%) containing inconspicuous nucleoli (94%) and moderate to abundant (59%), but occasionally scant (41%), pale to lightly eosinophilic (80%), sometimes vacuolated (17%), cytoplasm ( Figs. 8-10 ). The nuclei varied from pale to hyperchromatic ( Fig. 10 ). Cells with columnar morphology and basally located nuclei lined some follicles in 19 cases (27%) ( Fig. 11 ). Occasional tumors had minor foci in which the cells were somewhat spindled ( Fig. 12 ). Rare nuclear grooves were observed in 4 (6%). The mitotic count ranged from 0 to >100/10 high-power fields (HPF). Mitoses were abundant (Z10 mitosis/10 HPF) in 26 cases (37%), and apoptosis was prominent (> 20 apoptotic bodies in 1 HPF) in 32 (46%). Intratubular JGCT was seen in 43%, and entrapped seminiferous tubules were frequent (70%) at the periphery of the tumor. Lymphovascular invasion was present in 2 cases, rete testis involvement in 4, and necrosis in 1.
Uncommon to rare features or patterns included: regressed tumor foci with confluent hyalinization and prominent blood vessels (13%) ( Fig. 13A ), papillary growth (4%) (Figs. 2B, 13B), basaloid morphology (1%) ( Fig. 13C ), spindle cell predominance (1%), microcystic foci (1%) ( Fig. 6 ), adult granulosa cell-like patterns (1%) (Fig. 13D ), and hyaline globules (1%). The papillary pattern was characterized by tumor cells lining fibrovascular cores. The basaloid pattern comprised nests of small cells with scant cytoplasm with peripheral palisading. The adult granulosa cell-like pattern consisted of cells with oval to angulated nuclei with scant cytoplasm and occasional nuclear grooves. Inhibin (16/18), calretinin (8/9), WT1 (6/7), FOXL2 (12/12), SF-1 (12/12), and SOX9 (6/11) were positive, whereas SALL4 (9 cases) and glypican-3 (1 case) were consistently negative in the neoplastic granulosa cells; SALL4 occasionally highlighted the residual germ cells ( Fig. 14) . AFP was mostly negative (9/10); the 1 positive case showed only focal reactivity. Other commonly pos-itive markers were vimentin (7/7) and pancytokeratin (8/13).
Treatment and Follow-up
Sixty-two patients underwent gonadectomy, whereas 6 had wedge excision and 2 only biopsy. None underwent lymph node dissection or received adjuvant therapy. Follow-up information was available for 25 patients: 24, including 4 managed by wedge resection (3) or biopsy (1) and 1 case with necrosis, showed no evidence of disease (2 to 348 mo; mean, 83 mo; median, 61 mo), whereas 1 was alive at 260 months, but the disease status is unknown. Of our 24 cases with no evidence of disease, 12 had mitotic counts Z10/10 HPF; 5 of the 12 had counts in the range of 40 to >100/10 HPF.
DISCUSSION
Before the 1985 series of JGCT of the testis, 3 the characteristics of this tumor were not well defined, and the collective experience with this tumor remains limited. [5] [6] [7] [8] [9] [10] [11] [12] We have encountered patterns and cytologic features that have not been described in the literature or only to a minimal degree, which may potentially cause confusion with other neoplasms, most often yolk sac tumor (YST) or, rarely, other sex cord-stromal tumors. 13, 14 We therefore undertook a comprehensive morphologic analysis of testicular JGCT to highlight not only the classic features but also unusual aspects and those useful in differentiating it from other neoplasms.
Testicular JGCTs most frequently occur in the first 6 months of life and rarely arise in boys older than 1 year; only 4 in our series occurred beyond 1 year of age. The oldest patient reported with testicular JGCT was 27 years old. 8 They usually lack clinically evident endocrine manifestations; only 1 patient in our series had gynecomastia. Most are at least focally cystic grossly, but some are uniformly solid and may be tan, white to yellow. One microscopic finding that has not been emphasized in the literature is the characteristic lobular arrangement; this is especially helpful in cases that are afollicular or paucifollicular (Fig. 3A) . The predominant histologic patterns are a combination of follicular and solid; as in the ovary the follicles are variable in size and shape. The granulosa cells have moderate amounts of pale to lightly eosinophilic or vacuolated cytoplasm with round nuclei without grooves.
We encountered a few patterns that have not been previously described. Tumor cells lining fibrovascular cores formed a papillary architecture (4%). Basaloid foci (1%) showed nests of primitive "blue" tumor cells with peripheral palisading, resembling somewhat basal cell carcinoma. Predominance of spindle cells (1%) created a sarcomatoid appearance, and sheets of cells punctuated by small cysts resulted in a microcystic appearance (1%). The adult granulosa cell-like pattern (1%), although focal, had cells with oval to angulated nuclei with occasional grooves and scant cytoplasm.
Two types of stroma were seen in JGCT: fibrous and fibromyxoid. The latter type typically is somewhat basophilic occasionally imparting a chondroid appearance. In addition, foci of hemorrhage associated with hemosiderin-laden macrophages were seen in 16%; this and areas of hyalinization and prominent blood vessels (13%), which we consider regressed tumor, are previously unemphasized features of JGCT (Fig. 13A) . We have seen both in the ovarian JGCT sporadically. Another feature not previously described is the presence of columnar cells (Fig. 11 ). These were found lining cystic spaces and had basally located nuclei in 19 cases (27%). We hypothesize that these are of Sertoli cell origin, which is supported by their positivity for SOX9, a marker expressed in the (pre-) Sertoli cells of the testis. 15, 16 Although an intratubular component is reportedly rare, 17 we found it in 43% of our cases. This suggests that neoplastic proliferation of intratubular sex cord cells progresses to an invasive tumor, simultaneously acquiring granulosa cell differentiation and losing Sertoli cell differentiation as reflected in their FOXL2 reactivity (100%) (Fig. 14C ) and diminishing SOX9 reactivity (55%) (Fig. 14E) . At least some follicles may, therefore, represent expansion of this intratubular growth; this is supported by SALL4 occasionally highlighting residual germ cells at the base of these follicles (Fig. 14F ). Our FOXL2 staining result is in accordance with the reported consistent IHC expression of FOXL2 in JGCTs 18, 19 ; however, our experience has been that other testicular sex cord-stromal tumors may also express FOXL2, including Sertoli cell tumor, fibrothecoma, and myoid gonadal stromal tumor; therefore, FOXL2 positivity should not be considered specific.
Occasional JGCTs arise in undescended testes; 3 of the 6 in our series were previously included in the series of Lawrence et al, 3 and other rare reports exist. 20, 21 This is of course a phenomenon much more typical of germ cell tumors. [22] [23] [24] Another uncommon association is with a disorder of sexual development 4 ; we have only encountered 4 additional cases since the initial report. 4 The differential diagnosis of the JGCT may include a number of entities in the sex cord-stromal category as well as other categories. As the best known testicular tumor of the young is the YST, 14 we consider it first, and then discuss the differential with other sex cord-stromal tumors, followed, briefly, by other entities that are less often an issue.
In the differential with YST, the age is helpful as most boys with JGCT are less than 6 months old, whereas the majority of children with YST are older. 14, 25, 26 In the largest series of testicular YSTs, only 9% were less than 6 months old, and another 15% were 6 months of age or older but less than 1 year old. 14 One pitfall is that the typical serum AFP elevation seen in cases of YST is occasionally seen in patients with JGCT due to the physiological elevation seen in the early months of life; however, the levels are almost invariably lower than the pathologic levels associated with YST. 25, 27 Grossly, JGCTs more often exhibit a solid and cystic appearance, whereas the prepubertal YST usually lacks conspicuous cystic areas, but frequently the gross appearance is indistinguishable. On microscopic examination, the overt follicular differentiation of most JGCTs is very helpful. Follicles are not a feature of YSTs, although rarely cysts in the polyvesicular vitelline variant may simulate follicles. The rare polyvesicular YST 28 has not been reported in pure form in the testis and even in minor part is rare. However, cysts in YSTs may be misconstrued as dilated follicles of a JGCT, one of several problematic overlapping appearances of the 2 tumors (Fig. 6 ). True follicles are diagnostic of JGCT. When follicles are inconspicuous or absent in a JGCT, the differential with YST may arise when the former has foci that have a lace-like arrangement in a myxoid stroma resembling the reticular pattern of YST (Fig. 7B ). Potential confusion between JGCT and YST is compounded by the presence of solid foci in each of them. In a recent paper on YST of the infant testis 64% had solid foci. 14 Although a lowpower lobular arrangement is highly suggestive of JGCT, it may be seen in some YSTs. Despite the overlap just noted in individual tumors, careful evaluation of wellsampled neoplasms will show 1 or more features indicative of the correct diagnosis whether it be typical follicles of JGCT or Schiller-Duval bodies in YST. Brisk mitotic activity can be observed in both and is not a helpful differential feature. In difficult cases, IHC is helpful. Sex cord-stromal tumor markers such as inhibin, calretinin, and SF-1 are almost always positive in JGCT, whereas SALL4, glypican-3, and AFP are negative in the neoplastic granulosa cells. It is important to keep in mind, however, that not all JGCTs are conspicuously positive for inhibin, and 1 case (10%) in our series showed focal reactivity for AFP.
Although greater difficulty in differential diagnosis of the JGCT occurs with other sex cord tumors, particularly Sertoli cell tumor, it is worth briefly pointing out at this juncture the important differences from the adult type of testicular granulosa cell tumor. The latter occurs at a much older age, average 40 years, 12, 29 and has a spectrum of differences in morphology that has been elaborated in detail in discussion of these 2 tumors in the ovary, 30 and hence will not be repeated here.
The differential diagnosis of JGCT with Sertoli cell tumor and even unclassified sex cord-stromal tumor may be problematic, and indeed it must be noted that the inherent subjectivity that plays a role in tumor subclassification exists in this circumstance. There is a marked contrast in the morphology of the JGCT with the usual Sertoli cell tumor typically seen in adults. 31 However, some might interpret the corded patterns seen in some of our JGCTs as belonging in the Sertoli cell group, which may explain why some have reported "Sertoli cell tumors" as more common than JGCTs in the testis of children. 7 The follicles observed in JGCTs are typically larger than the lumens of tubules in Sertoli cell tumors; the former is also commonly multilayered in contrast to the single cell lining of the latter. In our opinion, an immature nuclear appearance and brisk mitotic rate are much more typical of JGCT than of Sertoli cell tumor, as is the lobular arrangement of tumor cells and myxoid stroma.
In cases that are paucifollicular, unclassified sex cord-stromal tumor enters the differential diagnosis. The latter, however, typically occurs in patients who are older than those with JGCTs, 6, 32 shows nonspecific solid and nested patterns without the lobular growth characteristic of JGCT, often has a more prominent and integral spindle cell component, and lacks distinct follicles with a circumferential arrangement of epithelioid tumor cells. 33 A rare, but important, differential is with a sarcoma, particularly embryonal rhabdomyosarcoma, given the primitive nuclei, mitotic activity, occasional spindle cell component in JGCTs, and sometimes a "small round blue cell tumor"-like appearance. However, sarcomas are most commonly located in the paratestis, although the testis may become secondarily involved. Furthermore, although primary testicular sarcomas of non-germ cell tumor origin rarely occur, 33, 34 none has been reported in infants. Other features of JGCT include follicular differentiation, absence of rhabdomyoblasts, and lack of myogenin reactivity, although there may be focal actin and desmin positivity. 35 One might think the JGCT would have a malignant potential given its frequent brisk mitotic activity and prominent apoptosis. In all of the reported cases with follow-up, however, the tumor has behaved in a benign manner. 3, 6, 7, 36 Although follow-up data were unavailable in many of our patients, those available showed no evidence of disease after long-term follow-up (12 >5 y); furthermore, we suspect we would have been made aware of bad outcomes had they transpired. The standard treatment of JGCT is radical orchiectomy; however, on the basis of its benign outcome, testis sparing surgery is now advocated. 36 Six patients in our series had wedge excision, and the 3 with follow-up showed no evidence of disease at 7, 30, and 68 months, respectively. One of the 2 patients who underwent biopsy had no evidence of disease at 16 months. The collective experience is supportive of testis sparing surgery.
In conclusion, testicular JGCT is a distinctive tumor that most commonly occurs in patients less than 6 months old and may occur in undescended testes and dysgenetic gonads. Its wide morphologic spectrum may potentially lead to a variety of issues in differential diagnosis, but awareness of its particular tendency to occur in the very young, the spectrum elaborated herein, and if necessary immunohistochemistry should enable the correct diagnosis to be made. On the basis of current experience, the prognosis seems very good, despite a frequently brisk mitotic rate.
